Anti-RAD/ RRAD/ RAD1 monoclonal antibody

Anti-RAD/ RRAD/ RAD1 antibody for FACS & in-vivo assay

Target products collectionGo to RRAD/RRAD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2312-Ab-1/ GM-Tg-hg-MP2312-Ab-2Anti-Human RRAD monoclonal antibodyHuman
GM-Tg-rg-MP2312-Ab-1/ GM-Tg-rg-MP2312-Ab-2Anti-Rat RRAD monoclonal antibodyRat
GM-Tg-mg-MP2312-Ab-1/ GM-Tg-mg-MP2312-Ab-2Anti-Mouse RRAD monoclonal antibodyMouse
GM-Tg-cynog-MP2312-Ab-1/ GM-Tg-cynog-MP2312-Ab-2Anti-Cynomolgus/ Rhesus macaque RRAD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2312-Ab-1/ GM-Tg-felg-MP2312-Ab-2Anti-Feline RRAD monoclonal antibodyFeline
GM-Tg-cang-MP2312-Ab-1/ GM-Tg-cang-MP2312-Ab-2Anti-Canine RRAD monoclonal antibodyCanine
GM-Tg-bovg-MP2312-Ab-1/ GM-Tg-bovg-MP2312-Ab-2Anti-Bovine RRAD monoclonal antibodyBovine
GM-Tg-equg-MP2312-Ab-1/ GM-Tg-equg-MP2312-Ab-2Anti-Equine RRAD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2312-Ab-1/ GM-Tg-hg-MP2312-Ab-2; GM-Tg-rg-MP2312-Ab-1/ GM-Tg-rg-MP2312-Ab-2;
GM-Tg-mg-MP2312-Ab-1/ GM-Tg-mg-MP2312-Ab-2; GM-Tg-cynog-MP2312-Ab-1/ GM-Tg-cynog-MP2312-Ab-2;
GM-Tg-felg-MP2312-Ab-1/ GM-Tg-felg-MP2312-Ab-2; GM-Tg-cang-MP2312-Ab-1/ GM-Tg-cang-MP2312-Ab-2;
GM-Tg-bovg-MP2312-Ab-1/ GM-Tg-bovg-MP2312-Ab-2; GM-Tg-equg-MP2312-Ab-1/ GM-Tg-equg-MP2312-Ab-2
Products NameAnti-RRAD monoclonal antibody
Formatmab
Target NameRRAD
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RRAD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RAD/ RRAD/ RAD1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP005125human RRAD Lentivirus plasmid
    ORF Viral VectorvGMLP005125human RRAD Lentivirus particle
    ORF Viral VectorpGMLPm000842mouse Rrad Lentivirus plasmid
    ORF Viral VectorvGMLPm000842mouse Rrad Lentivirus particle


    Target information

    Target IDGM-MP2312
    Target NameRRAD
    Gene ID6236,56437,83521,695086,611304,101087028,505165,100065651
    Gene Symbol and SynonymsRAD,RAD1,REM3,RRAD
    Uniprot AccessionP55042,P55043
    Uniprot Entry NameRAD_HUMAN,RAD_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166592
    Target ClassificationN/A

    The target: RRAD, gene name: RRAD, also named as RAD, RAD1, REM3. Predicted to enable GTP binding activity and calcium channel regulator activity. Predicted to be involved in small GTPase mediated signal transduction. Predicted to be located in cytosol. Predicted to be active in plasma membrane. Implicated in type 2 diabetes mellitus. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.